Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • News
    • News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
  • Toggle search form

[Disclosure] Hanwha Aerospace (012450) Reports Q1 2025 Preliminary Revenue of KRW 5.4842 Trillion, Up 278.5% YoY

Posted on April 30, 2025July 20, 2026 By K-STOCK Editor No Comments on [Disclosure] Hanwha Aerospace (012450) Reports Q1 2025 Preliminary Revenue of KRW 5.4842 Trillion, Up 278.5% YoY

Fact Source: Financial Supervisory Service DART / 2025-04-30

Disclosure Type: Preliminary Revenue/Operating Performance based on Consolidated Financial Statements (Fair Disclosure)

💡 3-Second Summary

Hanwha Aerospace has announced its preliminary consolidated financial performance for the first quarter of 2025, recording revenue of KRW 5.4842 trillion, up 278.5% compared to the same period last year. Operating profit reached KRW 560.8 billion, a 3068.4% increase YoY, though it decreased by 37.7% compared to the preceding quarter (Q4 2024).

📊 1. [Summary of Core Disclosure Content and Major Figures]

  • Q1 2025 Consolidated Preliminary Results (Unit: KRW):
    • Revenue: Quarter Performance 5,484.2B (KRW 5.4842T) (Up 13.7% QoQ / Up 278.5% YoY). Cumulative Performance 5,484.2B (KRW 5.4842T).
    • Operating Profit: Quarter Performance 560.8B (Down 37.7% QoQ / Up 3068.4% YoY). Cumulative Performance 560.8B.
    • Income Before Income Taxes: Quarter Performance 261.0B (Down 87.7% QoQ / Up 720.8% YoY). Cumulative Performance 261.0B.
    • Net Income: Quarter Performance 209.4B (Down 89.8% QoQ / Up 7953.8% YoY). Cumulative Performance 209.4B.
    • Net Income Attributable to Controlling Interest: Quarter Performance 86.6B (Down 95.3% QoQ / Turned to Profit YoY from KRW -13.1B in Q1 2024). Cumulative Performance 86.6B.
  • Information Disclosure Details: Prepared by the Finance Division and targeted at domestic and overseas investors and media. Communication remains managed via the IR Team (02-729-5200).
  • Accounting Standard & Note: Calculated pursuant to Korean International Financial Reporting Standards (K-IFRS). This data represents un-audited preliminary figures and remains subject to future modification during the external audit framework.

📈 2. [Expert View: What This Disclosure Means for Investors]

This filing details the quantitative parameters and financial metrics outlining Hanwha Aerospace’s corporate performance throughout the first quarter of 2025. The stated metrics represent un-audited consolidated numerical fields published purely for investor reference prior to the completion of the external accounting review.

In terms of quantitative variables, substantial growth is observed when compared against the historical baselines from the same period of the prior year (Q1 2024). Revenue expanded from KRW 1.4491 trillion to KRW 5.4842 trillion (up 278.5%), operating profit climbed from KRW 17.7 billion to KRW 560.8 billion (up 3068.4%), and net income attributable to controlling interest shifted from a loss of KRW 13.1 billion into a profitable metric of KRW 86.6 billion. However, when measured against the immediate preceding quarter (Q4 2024), while revenue advanced by 13.7%, profitability variables contracted significantly, showing declines in operating profit (-37.7%), income before taxes (-87.7%), and net income (-89.8%). Investors should monitor both the yearly expansion vectors and the quarterly profit contraction steps to cross-reference upcoming finalized reports.

📝 Editor’s Comment (by K-STOCK Editor)

Hanwha Aerospace’s latest informative filing officially designates the specific quantitative financial metrics and revenue allocations outlining its preliminary un-audited Q1 performance. A Year-over-Year turnaround into profitability was mathematically established for the net income attributable to controlling interest category.

The primary objective checkpoint for investors going forward is monitoring the alignment of these variables against the finalized statements. As explicitly underscored under the critical footnotes, these metrics are intermediate calculations compiled before the conclusion of the independent external audit, meaning the structured mathematical values remain subject to adjustments as accounting verification progresses.

Consequently, because the recorded quarter revenue of KRW 5.4842 trillion and operating profit of KRW 560.8 billion are provisional metrics, investors should independently cross-reference upcoming official quarterly reports to verify whether these baseline financial parameters match the final audited structures transparently.

📢 Disclaimer and Source Information

Source: This content was structured and newly written based on the official data submitted to the Electronic Disclosure System (DART) of the Financial Supervisory Service.

Investment Risk Notice: This information is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Defense

Post navigation

Previous Post: [Disclosure] Hanwha Aerospace (012450) Signs Amended Contract for ‘CBRN Reconnaissance Vehicle-II (Wheeled) Follow-up Production and 53 Other Items’ with DAPA
Next Post: [Disclosure] PSK Holdings (031980) Lays Down 5-Year Roadmap: 10% Revenue CAGR & 20%+ Operating Margin Through 2030

Related Posts

[Disclosure] Samsung Biologics (207940) Signs Mega CMO Contract Worth KRW 1.11T with European Pharmaceutical Company Disclosures
[Disclosure] Celltrion (068270) Submits Protocol Amendment for Phase 3 Trial of Keytruda Biosimilar ‘CT-P51’ in South Korea, Withholding Target Enrollment Figures Disclosures
[Disclosure] Celltrion (068270) Decides to Dispose of 7,043 Treasury Shares (Approx. KRW 1.03B) for Employee Stock Option Exercise Disclosures
[Disclosure] Alteogen (196170) Submits FY17 Audit Report; Confirms ‘Unqualified’ Audit Opinions and Turnaround to Profit Disclosures
Alteogen(196170) to Host Large-Scale Overseas IR in Hong Kong and Singapore, Unveiling R&D Pipelines to Global Institutional Investors Disclosures
[Disclosure] Celltrion (068270) Announces Future Plant Investment Plan of Up to KRW 700B for U.S. Facility Expansion to Respond to U.S. Drug Tariffs Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Alteogen (196170) Establishes August 6 as Record Date for Bonus Issue Share AllotmentJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Trading Suspension and Resumption Schedule for Stock Futures and OptionsJuly 16, 2026
  • [Disclosure] Alteogen (196170) Temporarily Suspends Plans for Relisting on the KOSPI MarketJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Temporary Trading Suspension on July 16 Due to Bonus Issue DecisionJuly 16, 2026
  • [Disclosure] Alteogen (196170) Decides on Bonus Issue of 0.3 Shares per 1 Common and Preferred ShareJuly 16, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme